In contrast, in a model of nerve injury, THC analgesia was found to be CB1- but not CB2-dependent (Casey et al., 2022), suggesting that the targets mediating cannabinoid analgesic responses may vary depending on the underlying pathophysiology of chronic pain conditions. The gene discussed is CNR2; the disease is injury.